VT-001 (Violet Therapeutics)

N/A

Report date: 2026/01/08 15:21:59
NME

Base Information

Drug NameVT-001 (Violet Therapeutics)
Drug Alias NameVT-001(Violet Therapeutics)VT-001
ClassificationSmall molecules
Mechanisms of ActionEphrin type-B receptor 3 inhibitors
TargetsEphrin type-B receptor 3
Therapy Area/IndicationsNeurodegenerative Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViolet Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesViolet Therapeutics
Inactive CompaniesN/A
Active IndicationsNeurodegenerative Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A